cellink

We’ve got another packed week of webinars and virtual events for you, starting with Hannover Messe 2021 on Monday. What else is coming up this week: ASTM CoE’s personnel certificate…

ASTM’s certificate course continues this week, and Cellink is discussing oncology drug screening applications in a webinar. Those are just two of the topics in this week’s webinar roundup, followed…

The current thesis on bioprinting goes a little something like this: bioprinting is a collection of a number of different technologies, all with potential. From inkjet, material extrusion, and stereolithography,…

Just days after Cellink signed its latest acquisition agreement with global system supplier Ginolis, the company has announced a new takeover, this time of MatTek. A global leader of in…

Since 2019, bioprinting pioneer Cellink (OTC: CCLKF / CLNK-B.ST) has gone from a $257 million market capitalization to a $1.5 billion-plus valuation. Before it went public in 2016, this new…

On this episode of the 3DPOD, we go into bioprinting. With us is Hector Martinez, the CTO and a co-founder of CELLINK (CLNK-B.ST). CELLINK is a bioprinting rocket ship which…

Automation, healthcare, metal additive manufacturing (AM), and bioprinting were the four big topics discussed at the 2021 Additive Manufacturing Strategies (AMS) summit. The two-day virtual event gathered experts for panel…

We’ve got a full slate of webinars and virtual events to tell you about for this upcoming week, including an AM Coalition Forum with a member of Congress, a 3D…

Even amid a world-halting pandemic that had companies across the world struggling to survive, leading bioprinting manufacturer Cellink has thrived thanks to its new high-profile product launches, successful acquisitions, and…

Looking back on 2020, it seems this unprecedented and tumultuous year has dealt a severe blow to businesses in every corner of the world. Even entire industries had to adapt…

In today’s 3D Printing News Briefs, an international research consortium of organizations is working to develop 3D bioprinted ankle implants. EnvisionTEC and Henkel are partnering to combine 3D printing and…

A crucial part of translating biomedical research and technology into space health means space crew will have to create their own functional cells, tissues, and even organs. Although the realization…

Taking a drug to market is a competitive, costly and challenging process involving preclinical laboratory and animal testing before the even more time-consuming and expensive four phases of human clinical…

Global bioprinting leader Cellink announced an agreement with the owners of Scienion AG, a German precision dispensing company, to acquire all company shares in an €80 million deal. Through this…

Startup Accelerator is an article series with a focus on new and exciting companies in the 3D printing space, in which 3DPrint.com speaks to startup leadership about their unique technologies…

Cellink partnered with Swiss medical technology manufacturer Kugelmeiers to offer a solution for more convenient and effective 3D cell culturing. The newly available Cellink Spheroid Kits combine Kugelmeiers’ Sphericalplate 5D…

Japanese researchers Jin Liu, Tatsuaki Tagami, and Tetsuya Ozeki have completed a recent study in nanomedicine, releasing their findings in “Fabrication of 3D Printed Fish-Gelatin-Based Polymer Hydrogel Patches for Local…

The unquestionably exciting field of 3D bioprinting is booming. It’s vibrant, determined, and sustained by a robust foundation of decades of research. Bioprinted organs aren’t yet being transplanted into human…

For over four years biotech company Cellink has been helping researchers pursue creative ways to promote organ regeneration, test novel drugs, develop vascularized bioconstructs, and more. Through collaborative partnerships and…

Finland is one of Europe’s most forested nations. Over 70 percent of the country’s boreal forest is covered with spruce, pine, downy birch, and silver birch. But beyond the splendor…

In only six years, Eric Gatenholm, along with his co-founding partner Hector Martinez, has moved from focusing on commercializing biotechnology startups to running one of the leading companies to offer…

The novel COVID-19 outbreak has altered the world at its core, transforming the foundation of most companies as economies begin to shut down to avoid a healthcare system collapse. In…

Studying cancer biology is among the top priorities for researchers around the world. From consortiums to universities, pharma companies, newcomers in the drug development industry, and research institutions, current research…

Seeking to strengthen their presence in Europe, 3D bioprinter provider and pioneer bioink company CELLINK, opened their new offices in Lyon, France, last October. Begining new partnerships and collaborations with…